Columbia Laboratories Inc. (CBRX)
-NasdaqCM 0.65 
0.02(2.72%) Jun 17, 3:59PM EDT
| Prev Close: | 0.66 |
|---|
| Open: | 0.66 |
|---|
| Bid: | 0.56 x 400 |
|---|
| Ask: | 0.78 x 400 |
|---|
| 1y Target Est: | 2.00 |
|---|
| Beta: | 1.45 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 0.64 - 0.67 |
|---|
| 52wk Range: | 0.55 - 1.23 |
|---|
| Volume: | 164,366 |
|---|
| Avg Vol (3m): | 325,595 |
|---|
| Market Cap: | 56.68M |
|---|
| P/E (ttm): | 10.96 |
|---|
| EPS (ttm): | 0.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Class Action Lawsuit against Columbia Laboratories Dismissed without PrejudiceBusiness Wire(Wed, Jun 12)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, Jun 12)
- Form 10 K for Columbia Laboratories, Inc.WILink(Wed, May 29)
- COLUMBIA LABORATORIES INC FinancialsEDGAR Online Financials(Fri, May 17)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Thu, May 9)
- Q1 2013 Columbia Laboratories Earnings Release - Before Market OpenCCBN(Thu, May 9)
- Columbia Laboratories Reports First Quarter 2013 Financial ResultsBusiness Wire(Thu, May 9)
- COLUMBIA LABORATORIES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 8)
- Speculative Bio Stocks For Investorsat Seeking Alpha(Wed, May 8)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Fri, May 3)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, May 2)
- Columbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9 Conference CallBusiness Wire(Thu, Apr 25)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or SEDGAR Online(Wed, Apr 24)
- Merck KGaA-CBRX Renew AgreementZacks(Thu, Apr 11)
- COLUMBIA LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, FEDGAR Online(Tue, Apr 9)
Key Statistics
| Forward P/E (1 yr): | 6.47 |
|---|
| P/S (ttm): | 2.06 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.07 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.02 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Columbia Laboratories, Inc. engages in the research, development, and commercialization of womens healthcare and endocrinology products. The company develops products by utilizing its proprietary bioadhesive drug delivery technologies to tre...
View More